Search results
AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY
Casper Star-Tribune· 6 days agoAmgen (NASDAQ:AMGN) today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody ...
My partner has avoided sex for 20 years, is she making excuses?
The US Sun· 2 days agoMore needs to be done to support these women, many of whom told the Royal College of Obstetricians...
BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore...
Morningstar· 7 days ago“Bezisterim” has been approved as the non-proprietary name for NE3107Data shows how bezisterim may be restoring homeostasis via specific genes associated with dementia, metabolism, and inflammation CARSON CITY, Nev., April 25, 2024